Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma
Wah Wah Aung, Chenyang Wang, Jia Xibei, Motoki Horii, Kie Mizumaki, Miyu Kano, Ai Okamura, Tadahiro Kobayashi, Takashi Matsushita
Topics & Concepts
TofacitinibJanus kinaseMedicineImmunologyScleroderma (fungus)Proinflammatory cytokineBleomycinCytokineCancer researchInflammationInternal medicineRheumatoid arthritisChemotherapyInoculationSystemic Sclerosis and Related DiseasesMultiple Sclerosis Research StudiesInflammatory Myopathies and Dermatomyositis